Ligand Pharmaceuticals
LGND
LGND
256 hedge funds and large institutions have $2.61B invested in Ligand Pharmaceuticals in 2017 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 111 increasing their positions, 95 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
256
Holders Change
-13
Holders Change %
-4.83%
% of All Funds
6.38%
Holding in Top 10
5
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-37.5%
% of All Funds
0.12%
New
26
Increased
111
Reduced
95
Closed
30
Calls
$11.9M
Puts
$36.3M
Net Calls
-$24.4M
Net Calls Change
-$8.3M
Top Buyers
| 1 |
BlackRock
New York
|
+$277M |
| 2 |
SCM
Scopia Capital Management
New York
|
+$68.1M |
| 3 |
William Blair Investment Management
Chicago,
Illinois
|
+$54.4M |
| 4 |
EVM
Eaton Vance Management
Boston,
Massachusetts
|
+$11.3M |
| 5 |
Renaissance Technologies
New York
|
+$10.7M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
276
Millennium Management
New York
| – | -$229K | -3,610 | Closed |
|
277
Citadel Advisors
Miami,
Florida
| – | -$210K | -3,312 | Closed |
|
|
AIM
278
Acrospire Investment Management
Chicago,
Illinois
| – | -$132K | -2,082 | Closed |
|
279
VanEck Associates
New York
| – | -$26K | -404 | Closed |
|
|
TRCT
280
Tower Research Capital (TRC)
New York
| – | -$20K | -313 | Closed |
|
|
AA
281
Ancora Advisors
Cleveland,
Ohio
| – | -$15K | -240 | Closed |
|
|
PHK
282
Point72 Hong Kong
Hong Kong
| – | -$13K | -199 | Closed |
|
283
Loomis, Sayles & Company
Boston,
Massachusetts
| – | -$11K | -175 | Closed |
|
|
MMG
284
Monetary Management Group
St Louis,
Missouri
| – | -$10K | -160 | Closed |
|